Structures by: Ananthan S.
Total: 5
3-Isopropyl-1-{2-[(1-methyl-1<i>H</i>-tetrazol-5-yl)sulfanyl]acetyl}-2,6-diphenylpiperidin-4-one hemihydrate
C24H27N5O2S,0.5(H2O)
Acta Crystallographica Section E (2013) 69, 11 o1598
a=28.7522(9)Å b=11.1809(4)Å c=16.5584(5)Å
α=90.00° β=115.303(2)° γ=90.00°
<i>N</i>'-[(<i>E</i>)-2-Chlorobenzylidene]-2-[(1,3,4-thiadiazol-2-yl)sulfanyl]acetohydrazide
C11H9ClN4OS2
Acta Crystallographica Section E (2011) 67, 10 o2612
a=7.551(5)Å b=8.743(3)Å c=11.269(5)Å
α=69.295(5)° β=87.493(4)° γ=78.892(5)°
3,3'-{[(Biphenyl-2,2'-diyl)bis(methylene)]bis(oxy)}bis[<i>N</i>-(4-chlorophenyl)benzamide]
C40H30Cl2N2O4
Acta Crystallographica Section E (2013) 69, 6 o914-o915
a=9.4761(2)Å b=11.9967(3)Å c=15.9238(4)Å
α=75.944(2)° β=86.1630(10)° γ=69.368(3)°
3,5-Dimethyl-1-{2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]acetyl}-2,6-diphenylpiperidin-4-one
C24H25N3O2S2
Acta Crystallographica Section E (2013) 69, 6 o845
a=9.1342(6)Å b=9.2874(6)Å c=27.0454(14)Å
α=90.00° β=90.00° γ=90.00°
3-Methyl-2,6-bis(4-methyl-1,3-thiazol-5-yl)piperidin-4-one
C14H17N3OS2
Acta Crystallographica Section E (2014) 70, 9 o1055
a=11.389(5)Å b=12.660(5)Å c=21.667(5)Å
α=90.000° β=90.000° γ=90.000°